Dr. Supreet Agarwal is a cancer biologist with over 12 years of translational research experience in clinical pharmaceutical sciences, particularly in cancer stem cells and biomarker-enabled drug discovery. Currently serving as a Senior Scientific Lead at Eli Lilly and Company, Dr. Agarwal's research focuses on mechanism-based cancer studies and drug response/resistance using sophisticated 3D organoid models. Previously, they completed postdoctoral work at the National Cancer Institute, contributing to the development of prostate cancer models and mechanisms of therapy resistance. Dr. Agarwal has authored 10 peer-reviewed publications and has led multiple preclinical trials, with two drugs currently in clinical trials. They hold a PhD in Clinical Pharmaceutical Sciences from the University of Iowa and a BS in Pharmacy from the Indian Institute of Technology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices